S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Abbott Laboratories Outlook is Healthy: Buy the Dip
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Abbott Laboratories Outlook is Healthy: Buy the Dip
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Abbott Laboratories Outlook is Healthy: Buy the Dip
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Abbott Laboratories Outlook is Healthy: Buy the Dip
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter

Rhythm Pharmaceuticals (RYTM) Insider Trading & Ownership

$38.45
-0.07 (-0.18%)
(As of 04/17/2024 ET)

Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.70%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$9.18 M
Get RYTM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rhythm Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RYTM Insider Buying and Selling by Quarter

Rhythm Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/2/2024Christopher Paul GermanCAOSell368$41.76$15,367.68  
3/21/2024Joseph ShulmanInsiderSell18,235$40.34$735,599.90  
3/19/2024David P MeekerCEOSell45,494$39.22$1,784,274.68  
3/19/2024Hunter C SmithCFOSell15,515$39.22$608,498.30  
3/19/2024Yann MazabraudEVPSell16,000$39.22$627,520.00  
2/14/2024Joseph ShulmanInsiderSell1,089$50.01$54,460.89  
2/12/2024Hunter C SmithCFOSell1,209$51.38$62,118.42  
2/12/2024Joseph ShulmanInsiderSell791$51.38$40,641.58  
2/12/2024Yann MazabraudEVPSell1,594$51.38$81,899.72  
2/9/2024Joseph ShulmanInsiderSell71,774$50.38$3,615,974.12  
12/27/2023Joseph ShulmanInsiderSell5,015$50.01$250,800.15  
12/5/2023Hunter C SmithCFOSell7,026$35.06$246,331.56  
11/24/2023Hunter C SmithCFOSell10,974$35.02$384,309.48  
11/8/2023Jennifer Kayden LeeEVPSell5,712$28.90$165,076.80  
11/3/2023Jennifer Kayden LeeEVPSell80$28.00$2,240.00  
9/5/2023Jennifer Kayden LeeEVPSell6,166$28.05$172,956.30  
8/9/2023Jennifer Kayden LeeEVPSell1,718$24.66$42,365.88  
8/7/2023Jennifer Kayden LeeEVPSell11,223$24.18$271,372.14  
7/26/2023Pamela J CramerInsiderSell930$17.64$16,405.20  
(Data available from 1/1/2013 forward)

RYTM Insider Trading Activity - Frequently Asked Questions

Who is on Rhythm Pharmaceuticals's Insider Roster?

The list of insiders at Rhythm Pharmaceuticals includes Christopher Paul German, David P Meeker, Hunter C Smith, Jennifer Chien, Jennifer Kayden Lee, Joseph Shulman, Pamela J Cramer, William T Roberts, and Yann Mazabraud. Learn more on insiders at RYTM.

What percentage of Rhythm Pharmaceuticals stock is owned by insiders?

4.70% of Rhythm Pharmaceuticals stock is owned by insiders. Learn more on RYTM's insider holdings.

Which Rhythm Pharmaceuticals insiders have been selling company stock?

The following insiders have sold RYTM shares in the last 24 months: Christopher Paul German ($15,367.68), David P Meeker ($1,784,274.68), Hunter C Smith ($1,389,580.94), Jennifer Chien ($50,033.17), Jennifer Kayden Lee ($654,011.12), Joseph Shulman ($4,712,362.62), Pamela J Cramer ($385,028.51), William T Roberts ($42,485.94), and Yann Mazabraud ($709,419.72).

How much insider selling is happening at Rhythm Pharmaceuticals?

Insiders have sold a total of 250,040 Rhythm Pharmaceuticals shares in the last 24 months for a total of $9,742,564.38 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:RYTM) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners